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ABSTRACT 
Acid azo dyes,  most of them naphtholdisulfonic acid derivatives, were given intraperitone- 
ally to rats and their effect  on "alkaline" ribonuclease activity was studied in total homog- 
enates of kidney cortex  and  liver.  Acid  treatment was  used  to  release  bound  enzyme 
activity.  Several  of  the  dyes,  including trypan  blue,  increased  RNase  activity in  both 
organs 3 days after administration of single doses,  while others, like Evans blue, were in- 
active. Activity was apparently bound to the sulfonic substitution in the 3,  6 positions in 
the naphthalene rings, substitutions in the  benzidine rings being not critical. All of the 
active and most of the inactive compounds were taken up by tubule cells of kidney cortex 
and by reticular and parenchymal cells of liver. While the effect on both liver and kidney 
was obtained 1 day after trypan blue administration, RNase remained increased for only 
about 3 days in the first organ, and for at least a month in the second. However, repeated 
trypan blue doses increased liver enzyme activity for at least 9 days. Serum RNase activity 
was  decreased  after  trypan blue administration. Ethionine administration together  with 
trypan blue markedly blocked the effect of the dye on liver RNase activity; simultaneously 
given methionine partially reversed  the  action of the  antimetabolite. This suggests  that 
de novo  synthesis of RNase is induced in liver by trypan blue. The action of ethionine on 
the kidney RNase response to trypan blue was less marked although significant; in view 
of the possible kidney uptake of the plasma enzyme, interpretation of this finding must be 
postponed. Results are discussed with reference to  the mechanism of the structural specificity 
of the compounds used, cytological localization of the dyes and their mechanism of action 
on liver and kidney RNase. 
Disclosure of the participation of ribonucleic acids 
in  the  mechanism of  protein  synthesis led  to  a 
renewal of interest in enzymes involved in RNA 
synthesis  and  degradation  (1).  Moreover,  the 
findings of Brachet (2) and others of in vivo effects 
of pancreatic ribonuclease (RNase)  on  a  variety 
of  single-celled  and  multicellular  organisms, 
pointed to  the need of further knowledge on the 
biochemistry and physiology of inter- and intra- 
cellular hydrolytic enzymes of this group  (cf.  3). 
Previous  work  from  this  laboratory  has  shown 
that  in  mammals  plasma  alkaline  RNase  is 
inactivated by the kidneys (4)  and suggested  that 
the  kidney enzyme could be  taken up  from  the 
plasma (5). 
During the  course of a  study on  the  effect  of 
administering several proteins on RNase  activity 
of the renal cortex (6), azo dyes known to be bound 
to  proteins were  also  assayed.  It was found that 
trypan  blue  and  some  related  dyes  increase 
105 RNase  activity  of  kidney  cortex  and  liver.  The 
time course  of this effect,  structural  requirements 
of  the  dye  molecules,  and  experiments  bearing 
on  the  mechanism  of  the  phenomenon  will  be 
presently described. 
MATERIALS  AND  METHODS 
Albino  rats  of  the  Wistar  strain,  both  males  and 
females, wcighing 100 to 200 gin. were used. The dyes 
were  dissolved in  saline  and  thc  solutions were  ad- 
ministered intraperitoncally in single or repeated in- 
jections of 5 ml.  per  100 gin. body weight.  The rats 
received the dyes in doses of from  1.7  to  30 mg per 
100 gm.  body weight  (of. Table I).  Control animals 
received  only  saline.  Trypan  bluc  was  purified  by 
ethanol extraction (7), and in some cxpc~'imcnts the 
ethanol-soluble  "rcd  fraction"  was  recovcrcd  and 
assayed.  In  a  few  expcrimcnts  animals were  simul- 
taneously treatcd with DL-cthionine (0.22 mmolcs per 
100 gm. body weight) with or without the administra- 
tion of nL-methioninc (0.25 or  1.25  mmoles per  100 
gin. body weight). 
Under  cther  anesthesia  kidney  cortex  and  liver 
samples (weighing 20 and 120 rag., respectively) were 
obtained, one before and the others at different time 
periods  after  experimental  treatments  were  started. 
Tissues were stored at -- 10°C. until assayed. Homoge- 
natcs were prepared in 0.05 M citric acid, neutralized 
with  0.25  M K:HPO4,  and  assayed  at  pH  7.3  as 
previously  described  (8).  Assays  were  performed  in 
triplicate on 0.17 rag.  kidney cortex or 3.0 mg. liver. 
In some experiments RNase  activity of blood serum 
was determined on 5 #l samples. It is known that acid 
treatment  (0.25  N  H2SO4)  unmasks  liver  alkaline 
RNasc  activity  (9).  Prcliminary  experiments  have 
shown that citric  acid  can be convcnicntly uscd for 
this  purpose,  giving similar activities as  the  H2SO4 
treatment.  Maximal activities were also obtained by 
making  homogenates  with  0.5  X  10  -8  M  n-ethyl 
maleimide  (cf.  10).  Results  of RNase  assays are ex- 
pressed either as arbitrary optical densities or in per- 
centages of the activity of initial biopsies. 
For  histological study of the dye  uptake,  formol- 
calcium-fixed pieces of kidney and liver were frozen 
sectioned,  the  sections  lightly  counterstained  with 
hematoxylin and mounted in balsam. 
Although,  for  descriptive  purposes,  means  and 
standard  errors  are  given,  in  the statistical  analysis 
of the results non-parametric tests  (11)  were mainly 
used. The significance level was taken at 0.05. 
RESULTS 
Effects  of  Different  Azo  Dyes  on  RNase  Activity  of 
Liver  and  Kidney:  Fig.  1  lists  the  dyes  assayed 
together  with  their  structural  formulae.  Table  I 
gives  the  RNase  activities  of  liver  and  kidney, 
in  percentages of the  initial  biopsies  3  days  after 
a  single injection of the dyes in the doses indicated. 
Doses are not uniform because of marked  toxicity 
or  low  solubility of some  of the dyes.  Each  com- 
pound was assayed in at least two separate experi- 
ments. 
It can  be seen  that  the dyes used fell into  two 
groups.  The  active  ones  (Fig.  1,  left  column) 
included  symmetrical  dyes  of  the  trypan  blue 
type,  with sulfonic groups  in  positions 3  and 6  of 
the naphthalene rings (C.I.  (color index) numbers 
23850,  24400,  22610,  24340,  and  Dye  A).  Two 
other  asymmetrical  dyes  were  also  active; in one 
of  them  (C.I.  22590)  the  sulfonic  group  in 
position  3  of  one  of  the  naphthalene  rings  was 
lacking  and  the  amino  group  in  the  same  ring 
shifted  to  position  2.  The  other active  dye was  a 
more complex trisazo compound (Dye B, Table I), 
in which positions 3 and 6 of the terminal naphth- 
alene  rings  were  also  substituted  with  sulfonic 
groups. 
In view of the above mentioned non-uniformity 
of dosage, and lack of information as to the actual 
dye content of the samples used, no stress is being 
placed on  the differences in response towards  the 
dyes of this group.  It seems, however,  that, except 
for the hydroxyl group in position 8  of the naph- 
thalene rings, which was present in all of the dyes 
assayed,  the  other  substitutions in  these  rings  as 
well as in the benzidine rings were not critical. 
To  the  inactive  group  of  dyes  (Fig.  1,  right 
column)  belonged  the  symmetrical  compounds 
Evans  blue  and  Niagara  sky  blue  6  B,  which 
have  sulfonic groups  in  positions  2  and  4  of  the 
naphthalene rings  (C.I.  23860  and  24410).  Two 
other  symmetrical  and  less  sulfonated  dyes  (C.I. 
22120  and  23685)  were  also  inactive.  The  other 
available  dyes  of  this  group  were  asymmetrical 
and had sulfonic substitution in the 3,  6  positions 
in only one of the naphthalene rings  (C.I.  30280 
and 22445).  The ethanol extracted red fraction of 
trypan  blue  was  also  inactive;  no  significant 
variation  in  liver  and  kidney  RNase  was  found 
in the saline-injected rats. 
Examination  of  the  tissue  sections  revealed 
uptake  of all  of the  dyes,  with  the  exception  of 
acid red 33 and the red fraction, by both reticular 
and  parenchymal  cells of the  liver and  proximal 
convoluted  tubules  of  the  kidney.  The  two  last 
mentioned  dyes  were  rapidly  excreted  in  the 
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Structural formulae and Color Index names and 
urine.  As  no  quantitative  observations  could  be 
performed  on  the  dye  uptake,  no  correlation  of 
dye  uptake  with  effect on  RNase  activity could 
be made at present. 
Time  Course  of  Liver  and  Kidney  RNase  Activity 
after  Single  Injections  of  Trypan  Blue:  Table  II 
gives the combined results of two experiments on 
rats  receiving  10  mg of trypan  blue  per  100  gin. 
body  weight.  In  one  of the  experiments  biopsies 
were performed  at times 0,  1,  3,  and  8 days after 
the  injection;  in  the  other  they  were  made  at 
times  0,  3,  15,  and  30  days.  It can  be  seen  that 
saline-injected  animals  presented  non-significant 
variations  of RNase  activity of kidney  and  liver. 
In the dye-treated animals, however, the behavior 
of both  organs  was  different.  In  kidney,  activity 
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numbers of the dyes studied  (cf. Table I). 
was  already  high  1  day  after  injection  and  re- 
mained  at  high  levels up  to  the  30th  day,  when 
the  experiment  was  terminated.  In  the  liver,  on 
the other hand, significant increases were obtained 
at  1 and  3 days only, activities dropping  to initial 
levels at 8 days and thereafter. 
Effect  of  Repeated  Trypan  Blue  Administration  on 
RNase  Activity  of  Liver:  To  find  out  whether 
RNase  activities of liver could  be  maintained  at 
high levels by repeated trypan  blue injections, an 
experiment was performed  on 20 rats,  of which 5 
received  saline  injections  throughout  (Fig.  2). 
The remaining  15 received  5  rag. of tyrpan  blue 
per  100  gin. body weight at time 0. At 3 days and 
thereafter,  5  rats  of  lhis  group  received  saline, 
while the remaining 10 received a second injection 
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I~IGURE 
Alkaline  RNase  activity  (ordinates) 
after  single  or  repeated  trypan  blue 
doses.  Abcissae: time in days.  Standard 
errors given by vertical bars. Number of 
animals sampled at each time period is 
shown  on  the  curves.  Letters  indicate 
means referred to in text and in Table 
III. 
of dye.  On  the  6th  day,  of  these  remaining  10, 
another group of 5 was put on saline, whereas the 
remaining  5  received  a  3rd  injection of the  dye. 
All the animals were biopsied at times 0,  3, and 6 
days; on the 9th day the rats were sacrificed. 
Statistical  analysis  of  the  results  (Table  III) 
shows that at 3 days the effect of a  single injection 
of the  dye  was  at  the  limit of significance  (com- 
parison  a-b).  On  the  6th  day,  animals  receiving 
2  doses  of  dye  (c)  had  significantly  higher  liver 
TABLE  III 
Results  of Statistical Analysis (Mann-Whitney 
Test)  (12)  of Data Summarized  in Fig. 2 
Time  Comparison  Probability 
3 days  a--b  >.05  <. 10 
c-e  <.02 
6  days  e-d  >  .4 
c-d  =  .02 
f-h  =  .004 
f-i  =  .004 
f-g  =  .004 
9  days  g-h  >  .3 
g-i  =  .004 
h-i  =  .004 
* Explanation of symbols is given  in  Fig.  1  and  in 
the text. 
enzyme  activities  than  those  receiving  1  dose  (e) 
or saline  (d).  These last two groups did not differ 
significantly.  On  the  9th  day,  rats  receiving  3 
doses of dye  (f)  differed significantly from saline- 
injected  rats  (h)  and  from  animals injected  once 
(i)  or  twice  (g)  with  trypan  blue.  Whereas  the 
2-doses  group  (g)  did  not  differ  from  control 
animals (h), the group injected with  1 dose of dye 
and  with  saline  thereafter  (i)  dropped  its RNase 
activity  to  levels  below  the  control  ones.  This 
explains  the  significant  differences  between  this 
group and the others on the 9th day (comparisons 
g-i, f-i,  and h-i). 
Effect  of  Trypan  Blue  on  Serum  RNase  Activity: 
Serum was assayed in view of a  suggested relation- 
ship  between  plasma  and  kidney  cortex  RNase 
TABLE  IV 
Effect of Trypan  Blue  Administration*  on 
Serum RNase Activity 
Treatment  1  day  3  days 
Saline  74.6  4-  14.0  (6):~  70.4  i  7.8  (6) 
Trypan blue  72.8  4-  4.0  (8)  62.1  4-  7.3  (7) 
* 7 mg./lO0  gm.  body weight.  Same  animals were 
sampled at times O,  1, and 3 days. 
Mean =h standard error  (number of animals). 
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Effect  o/ Ethionine  Administration  on  Trypan  Blue-Induced  Increase in  Liver  and  Kidney  RNase  Activity* 
Treatment and total dose~  Liver  Kidney 
Saline 
Ethionine  (37 mg./100 gm.) 
Trypan blue  (15 mg./100 gin.) 
Trypan blue +  ethionine 
Trypan blue -[- ethionine +  methionine (37 
mg./100 gm.) 
Trypan blue +  ethionine 4- methionine (185 
mg./100 gm.) 
96.8  4-  6.0  (11)§ 
78.4  4-  8.0  (5) 
200.8  4-  13.6  (12) 
116.1  -4-  6.3  (13) 
110.3  4-  5.3  (6) 
157.9  4-  11.5  (6) 
100.0  4-  11.8  (10) 
85.5  4-  18.6  (5) 
350.1  -4-  50.7  (12) 
193.7  4-  18.6  (13) 
249.8  -4-  27.8  (6) 
310.3  ±  87.3  (6) 
* Results in percentages of initial biopsies; liver and kidney data refer to same animals. 
:~ Drugs administered in 2 doses, at 36 hour interval; experiments terminated 72 hours after first injection. 
2nd dose was half of first. 
§ Mean ±  standard error  (number of animals). 
activity  (3).  It can be seen in Table IV that both 
saline  and  trypan  blue  administration  reduced 
blood  serum  RNase  activity  to  levels  below  the 
initial ones. 
Effect  of  Ethionine  Administration  on  the  Response o/ 
Liver  and  Kidney  RNase  to  Trypan  Blue."  Analysis 
of  the  results  summarized  in  Table  V  indicates 
that ethionine in  a  total  dose  of 0.22  mmoles per 
100  gin.  body  weight  intraperitoneally  adminis- 
tered  together with  trypan  blue  markedly  inhib- 
ited  the  increase  in  liver  RNase  activity.  The 
effect  on  kidney  was  of  smaller  magnitude, 
although  also  statistically  significant.  Ethionine 
alone,  in  the  rather  small  sample  of  animals 
studied,  did  not  significantly  influence  liver  and 
kidney  RNase  activity.  Methionine  given  at  the 
level of 1.25  mmoles per  100 gm.  but not at 0.25 
mmoles  per  100  gm.  significantly  counteracted 
the  effect  of ethionine on  the  liver,  while  in  the 
case of the kidney the effect was not significant at 
both dosage levels. 
D ISCUSSION 
The  above  results show  that  after  administration 
of certain azo dyes distinct increases are found  in 
alkaline  RNase  activities of total homogenates  of 
liver and kidney.  Interpretation of the findings is 
not unequivocal  in view of the complexity of the 
system  studied--the  whole  animal--and  lack  of 
knowledge  concerning  cytological  fate  and  me- 
tabolism  of  the  administered  dyes.  It  may  be 
stated  that repeated  attempts failed  to  reproduce 
the  results  in  liver  slices  incubated  with  Ringer- 
phosphate-glucose  or  with  1 : 1  serum-Ringer 
medium containing trypan  blue for up to 3  hours 
at 37°C.  with oxygenation. However, examination 
of sections of the slices failed to reveal any uptake 
of the dye. 
Structural Specificity of the Dyes:  Attention is called 
to  the  fact  that  one  essential  requirement  for 
activity  was  sulfonation  in  positions  3  and  6  of 
the naphthalene rings.  Some  of the dyes used  are 
known to be variously  bound to plasma albumin, 
the binding of the 2, 4 isomers being stronger than 
that of 3, 6 isomers (12,  13). The hypothesis could 
therefore  be  held,  at  least  for  trypan  blue  and 
Niagara blue 2B on the one hand, and Evans blue 
and Niagara  sky blue  6B on  the other,  that their 
different  behavior  is  due  to  the  fact  that  less 
free dye  is available  to  enter cells  because of the 
stronger  binding  to  albumin  of  the  two  last 
mentioned  compounds.  It  is  also  conceivable 
that  the  intracellular  pathways  and  fate  of  al- 
bumin-combined  dye  could  be  different  from 
those of the free dye. Ultrastructural investigations 
of  the  intracellular  localization  of  some  of  the 
dyes used  would  be of interest  (14,  15).  Study  of 
other  colloids  taken  up  by  cells  could  help  to 
clarify the understanding of the  phenomenon.  So 
far,  experiments  not  here  reported  have  shown 
that  the  administration  of  colloidal  thorium 
dioxide  (Thorotrast,  testagar)  is  without  effect 
on liver and kidney RNase activity. 
Different  Behavior  of Kidney  and  Liver  RNase  toward 
Trypan  Blue:  Our  results show  that the effect of 
trypan  blue  on  kidney  cortex  RNase  activity 
lasts much longer  than does  the effect of the dye 
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ability of these organs  to metabolize  the dye.  No 
data could be found on the enzymatic breakdown 
of  the  dyes  used.  However,  the  carcinogenic 
monoazo dyes are known to have their azo groups 
reduced  at  a  more  rapid  rate  by  liver  than  by 
kidney  slices  or  homogenates  (cf.  16).  Repeated 
administration of trypan blue was able to maintain 
RNase increase in liver for at least 9 days; it may 
be stated  here that, except for a  chance variation 
no other explanation can be given of the behavior 
of  the  1-dose  group  sampled  on  the  9th  day 
(Fig. 2). 
Cytological Localization  of Trypan Blue:  No detailed 
discussion  will  be  given  of  the  classical  contro- 
versies  on  intracellular  localization  of  acid  col- 
loidal  dyes  in  liver  (17)  and  kidney  (18),  and 
their  binding  to  proteins  (19).  On  the  basis  of 
centrifugal  fractionation  of sucrose  homogenates 
of liver, it has  been suggested  that  trypan  blue is 
bound to the mitochondrial fraction (20).  Caution 
should  be exercised,  however,  in interpreting  this 
result, for most of the dye is found in the reticulum 
cells, which contribute  but little to the mitochon- 
drial fraction of the total homogenate.  In view of 
the non-homogeneity of the mitochondrial fraction 
(see  below),  this  work  would  be  profitably  con- 
trolled  by  biochemical  analysis  of  the  fractions. 
The more recent findings of Straus  (21)  on  the 
concentration of horseradish  peroxidase in kidney 
droplets  enzymatically  similar  to  de  Duve's 
lysosomes  (22;  see  also  23-25),  as  well  as  other 
morphological  data,  (e.g.  26,  27),  suggest  that 
trypan  blue  (presumably  bound  to  protein)  is 
segregated  in  a  similar  cellular  fraction.  In  an 
electron  microscopic  study,  Schmidt  (15)  has 
recently  reported  that  trypan  blue  administered 
to  mice  is  found  in  kidney  cells  as  granules, 
frequently clustered  and without any relationship 
to either the mitochondria or the Oolgi region. 
Straus  (28)  has  also  found  that  "acid"  RNase 
activity of kidney  homogenates  is increased  after 
egg-white  administration  to  rats,  together  with 
increase of other hydrolytic enzymes belonging to 
the  lysosome fraction.  The  data  available on  the 
intracellular distribution of "alkaline" RNase are, 
however, conflicting (see 29), so that the relation- 
ship  of  our  results  to  Straus's  data  must  await 
further  information.  Study  of the effect of trypan 
blue  on  other  enzymatic  systems  of  liver  and 
kidney is under way. 
Mechanism  of  the  Effect  of  Trypan  Blue  on  Kidney 
RNase:  It  was  previously  suggested  (cf.  6)  that 
an  increased  kidney  cortex  RNase  activity could 
be  due  to  (a)  heightened  reabsorption  or  (b) 
decreased  inactivation of the enzyme; to this may 
be  added  (c)  the  in  situ  synthesis  of the  protein. 
As no increase in serum RNase activity was found 
after trypan blue administration,  and as variations 
in  glomerular  filtration  rate  or  reabsorptive 
activity are very improbable,  the first mechanism 
may  be  ruled  out.  The  ethionine  experiment 
suggests  that  the  trypan  blue-induced  RNase 
increase could be due  to synthesis of the enzyme. 
However,  the  effect  of  ethionine  on  protein 
uptake  by  the  kidney  should  be  studied  before 
any  definite  choice  can  be  made  between  the 
second and  third  mechanisms. 
De  Novo  Synthesis  of  RNase  Induced  in  Liver  by 
Trypan Blue:  Although  the  interpretation  of the 
ethionine  experiment  as  regards  kidney  must 
await further  information,  results on liver suggest 
that  trypan  blue  induces  an  increased  synthesis 
of RNase in that organ.  It is known that ethionine 
administration  is  able  to  inhibit  a  number  of 
adaptive  and  non-adaptive  increases  in  enzyme 
activity  (30,  31).  It  should  be  pointed  out  here 
that no evidence could be obtained for the uptake 
of liver RNase from the plasma:  (a) no correlation 
was  found  in  normal  rats  between  serum  and 
liver RNase  activity, and  (b)  no  increase  in liver 
RNase  activity  was  obtained  at  various  periods 
after bilateral  nepbrectomy  in  the rat,  in spite of 
high  levels  of  serum  enzymatic  activity  (un- 
published  data).  Results  of the  ethionine  experi- 
ment  would  also  be  hard  to  reconcile  with  the 
hypothesis  that  trypan  blue  interferes  with  cata- 
bolic  systems  that  intracellularly  would  degrade 
RNase.  It  may  also  be  stated  that  preliminary 
experiments  showed  no  variation  in  liver super- 
natant  RNase  inibitor  (32)  after  trypan  blue 
administration  (unpublished  data). 
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